Bendamustine HCl 25 mg
Bendamustine HCl 100 mg
Argentine Industry - Dispense under prescription
Qualitative and quantitative composition:
Each Bentaman® 25 glass bottle contains:
Bendamustine HCl 25.0 mg
Mannitol 42.5 mg
Each Bentaman® 100 glass bottle contains:
Bendamustine HCl 100.0 mg
Mannitol 170 mg
Chronic lymphocytic leukaemia (CLL)
Bentaman is indicated for the treatment of patients with chronic lymphocytic leukaemia. The efficacy of primary therapies other than chlorambucil has not been established.
Non-Hodgkin’s lymphoma (NHL)
Bentaman lyophilised injection is indicated for the treatment of patients with indolent B-cell non-Hodgking lymphoma that has progressed during or within six months of treatment with rituximab or a rituximab-containing regime.
Bentaman® 25 lyophilised injection: cartons containing one amber 14-ml glass bottle.Bentaman 100 lyophilised injection: cartons containing one amber 50-ml glass bottle.
Store at room temperature (below 30°C) inside the marketed packing.
Medicinal speciality authorised by the Ministry of Health.
Certificate Nº 56692
Laboratorio DOSA S.A.
Girardot 1369 (C1427AKC) City of Buenos Aires, Argentina.
Pharmaceutical Director: María C. Terzo, Pharmacist.